home / stock / txg / txg news


TXG News and Press, 10x Genomics Inc.

Stock Information

Company Name: 10x Genomics Inc.
Stock Symbol: TXG
Market: NASDAQ
Website: 10xgenomics.com

Menu

TXG TXG Quote TXG Short TXG News TXG Articles TXG Message Board
Get TXG Alerts

News, Short Squeeze, Breakout and More Instantly...

TXG - 10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that ...

TXG - Neutral Recommendation Issued On TXG By UBS

2025-08-08 10:15:19 ET UBS analyst issues NEUTRAL recommendation for TXG on August 8, 2025 11:45AM ET. The previous analyst recommendation was Neutral. TXG was trading at $12.06 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...

TXG - Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2025 Update

2025-08-07 21:09:12 ET This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 07/30/2025.... Read the full article on Seeking Alpha ...

TXG - 10x Genomics to acquire Scale Biosciences

2025-08-07 16:32:10 ET More on 10x Genomics 10x Genomics: Stuck In Neutral Life sciences tools companies higher as NIH pauses cancellation of research grants Bruker and 10x Genomics reach global settlement of patent litigation Seeking Alpha’s Quant Rat...

TXG - 10x Genomics GAAP EPS of $0.28 beats by $0.65, revenue of $172.9M beats by $33.39M

2025-08-07 16:20:31 ET More on 10x Genomics 10x Genomics: Stuck In Neutral Life sciences tools companies higher as NIH pauses cancellation of research grants Bruker and 10x Genomics reach global settlement of patent litigation Seeking Alpha’s Quant Rat...

TXG - 10x Genomics Reports Second Quarter 2025 Financial Results

10x Genomics Reports Second Quarter 2025 Financial Results PR Newswire PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter end...

TXG - 10x Genomics to Acquire Scale Biosciences

10x Genomics to Acquire Scale Biosciences PR Newswire Acquisition Will Further Expand Chromium's Capabilities PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today anno...

TXG - Expected US Company Earnings on Thursday, August 7th, 2025

Leatt Corp (LEAT) is expected to report for Q2 2025 MDU Resources Group Inc. (Holding Company) (MDU) is expected to report $0.13 for Q2 2025 Video Display Corp. (VIDE) is expected to report for quarter end 2025-05-31 Alarm.com Holdings Inc. (ALRM) is expected to report $0.38 for Q2 20...

TXG - Expected earnings - 10x Genomics Inc.

10x Genomics Inc. (TXG) is expected to report $-0.35 for Q2 2025

TXG - 10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery PR Newswire Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases ...

Next 10